Al Root

GE HealthCare Technologies' stock rose early Wednesday after the company reported better-than-expected quarterly results and offered a solid outlook for the new year.

On Wednesday, the medical-imaging company announced fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion. A year ago, GE HealthCare reported earnings per share of $1.45 from sales of $5.3 billion.

Sales grew, but earnings didn't, partly because of the impact of tariffs, which increased costs by about $100 million. Operating profit margins were about 16.7%, down two percentage points year over year.

Overall, the results look solid. GE HealthCare shares were up 1% at $79.56, while S&P 500 and Dow Jones Industrial Average futures were up 0.2% and 0.3%, respectively.

Guidance helped, too. For 2026, management expects earnings per share of between $4.95 to $5.15 from sales of about $21.3 billion, up about 3.5% year over year. Wall Street projects earnings per share of $4.94 from sales of $21.4 billion, up about 4% year over year.

The quarter is a relief for investors. Shares have struggled as a mix of tariffs, Chinese competition, and a generic version of GE's Omnipaque, an imaging contrast agent, weighed on investor sentiment.

Coming into Wednesday trading, GE Healthcare's stock was down about 10% over the past 12 months.

Write to Al Root at allen.root@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

February 04, 2026 07:03 ET (12:03 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.